EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Prescription Drug Monitoring Programs on Postpartum Opioid Prescribing Practices

Sai Vijay Trilochan Reddy Tadi iD, CeCe Cheng iD, Alexander Testa iD, John J Byrne, Carolina Vivas-Valencia iD

Health Services Research · 2026-06 · 61 (3)

DOI: 10.1111/1475-6773.70123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Services Research, online erschienen am 04.05.2026. Verfasst von Sai Vijay Trilochan Reddy Tadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Prescription Drug Monitoring Programs, Analgesics, Opioid, Practice Patterns, Physicians', Postpartum Period. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the association between Prescription Drug Monitoring Programs (PDMPs) and postpartum opioid prescribing from 2007 to 2015, prior to the 2016 Centers for Disease Control and Prevention opioid prescribing guidelines, and to assess differences between low‐ and high‐risk populations. Study Setting and Design This cross‐sectional study captures delivery episodes across the United States, primarily from commercially insured patients. The exposure was the implementation of PDMPs at the state level from 2007 to 2015, with states classified by whether implementation occurred before or after 2016. We used a difference‐in‐difference design for analysis. The primary outcome included: (1) morphine milligram equivalents (MME) per day; (2) pills dispensed; (3) average days' supply, and (4) total number of prescriptions filled during the postpartum period (42 days after delivery). Data Sources and Analytic Sample We analyzed secondary data from IQVIA PharMetrics, an administrative claims database from 2006 to 2015. We identified reproductive‐age patients (ages 12–59) with a documented delivery and stratified them into low and high‐risk groups by postpartum prescribing and pre‐delivery opioid exposure. Principal Findings Among 361,165 delivery episodes (9.9% cesarean, 90.1% vaginal), PDMP implementation was not associated with changes in postpartum opioid prescribing. In an age‐and comorbidity‐adjusted analysis by risk groups, PDMP implementation was not associated with statistically significant changes in MME per day per delivery in either low‐risk (−0.35; 95% CI, −3.27 to 2.57) or high‐risk groups (1.11; 95% CI, −7.46 to 9.68) in the implementation year, and results for pills dispensed, days' supply, and total prescriptions were similarly null, with confidence intervals spanning zero.

Conclusion

State‐level PDMP implementation was not associated with changes in postpartum opioid prescribing. These findings suggest PDMPs alone may be insufficient to influence postpartum prescribing, highlighting the need for alternative strategies to optimize pain management and reduce opioid‐related risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prescription Drug Monitoring ProgramsAnalgesics, OpioidPractice Patterns, Physicians'Postpartum PeriodHumansFemaleUnited StatesAdultCross-Sectional StudiesAdolescentMiddle AgedYoung AdultPregnancyChild

Stichwörter der Autor:innen

PDMPsopioid prescriptionpostpartumstate mandates

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Department of Biomedical Engineering and Chemical Engineering, University of Texas at San Antonio, San Antonio, Texas, USA.
  • Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Washington, Seattle, WA, USA.
  • Department of Management, Policy and Community Health, School of Public Health, University of Texas Health Science Center at Houston, San Antonio, Texas, USA.
  • Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

ORCID-Profile: Sai Vijay Trilochan Reddy Tadi, CeCe Cheng, Alexander Testa, Carolina Vivas-Valencia

Zitieren

APA

Tadi, S. V. T. R., Cheng, C., Testa, A., Byrne, J. J., & Vivas-Valencia, C. (2026). Impact of Prescription Drug Monitoring Programs on Postpartum Opioid Prescribing Practices. Health Services Research, 61(3). https://doi.org/10.1111/1475-6773.70123

Vancouver

Tadi SVTR, Cheng C, Testa A, Byrne JJ, Vivas-Valencia C. Impact of Prescription Drug Monitoring Programs on Postpartum Opioid Prescribing Practices. Health Services Research. 2026;61(3). doi:10.1111/1475-6773.70123

BibTeX
@article{Tadi2026,
  author = {Tadi, Sai Vijay Trilochan Reddy and Cheng, CeCe and Testa, Alexander and Byrne, John J and Vivas-Valencia, Carolina},
  title = {Impact of Prescription Drug Monitoring Programs on Postpartum Opioid Prescribing Practices},
  journal = {Health Services Research},
  year = {2026},
  volume = {61},
  number = {3},
  doi = {10.1111/1475-6773.70123}
}
Kostenlos starten →